Impact of Metabolic Activity Driving Precision in Diagnostic Bronchoscopy with Dr. Steven Kovacs

Lung cancer remains the most lethal cancer worldwide, and traditional biopsy approaches still leave critical gaps. In this episode, interventional pulmonologist Dr. Steven Kovacs shares how real-time metabolic imaging inside the bronchoscopy suite is transforming how clinicians assess biopsy adequacy.Episode Breakdown00:00 – Opening remarks: the challenge of lung cancer diagnosis01:17 – Introducing Dr. Steven Kovacs02:11 – Journey through bronchoscopy: from navigation to robotics05:11 – The problem with current biopsy yields and ROSE07:29 – Why imaging tool-in-lesion is not enough09:59 – Metabolic activity as a new “PET scan for cells”12:16 – How dynamic cell imaging works in real time14:45 – Preserving tissue for pathology and sequencing17:15 – Differentiating inflammation, necrosis, and malignancy in the same lesion19:37 – Case studies: when pathology said “negative,” but malignancy was present22:01 – Adequacy as a clinical responsibility, not just pathology’s burden24:07 – The future of bronchoscopy workflows and precision medicine27:32 – Audience Q&A: diagnostic adequacy and workflow efficiency30:52 – Audience Q&A: reducing procedure time and anesthesia costs34:41 – Audience Q&A: handling tissue and specimen prep38:18 – Audience Q&A: impact on indeterminate biopsies43:12 – Audience Q&A: adequacy for NGS and downstream testing47:20 – Hospital administration and value analysis: time savings and cost impact50:05 – Surgical use cases and margin evaluation52:25 – Adoption and workflow integration: overcoming learning curves53:32 – Closing thanks and replay reminderAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠GrowMyMedtech.com⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channel⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠Subscribe to our LinkedIn Newsletter⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠Follow The State of MedTech onLinkedIn ⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠Instagram ⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠TikTok ⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠X ⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠Facebook ⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠Follow Omar M. Khateeb onLinkedIn ⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠Instagram ⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠TikTok ⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠X ⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠Facebook ⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.#Medtech #LungCancer #Diagnostics #Pulmonology #HealthcareInnovation